Basic information Safety Supplier Related

None

Basic information Safety Supplier Related

None Basic information

Product Name:
None
Synonyms:
  • BI-1347 (BI1347)
  • 1H-Pyrazole-1-acetamide, 4-[4-(4-isoquinolinyl)phenyl]-N,N-dimethyl-
  • 2-(4-(4-(Isoquinolin-4-yl)phenyl)-1H-pyrazol-1-yl)-N,N-dimethylacetamide
  • BI-1347,None,2-{4-[4-(isoquinolin-4-yl)phenyl]-1H-pyrazol-1-yl}-N,N-dimethylacetamide
  • BI1347,oral activity,human NK92MI cell,BI-1347,Inhibitor,CDK,mouse splenic NK cell,BI 1347,anti-tumoral activity,inhibit,Cyclin dependent kinase,selectivity
  • BI-1347, 10 mM in DMSO
  • B1-1347
CAS:
2163056-91-3
MF:
C22H20N4O
MW:
356.42
Mol File:
2163056-91-3.mol
More
Less

None Chemical Properties

storage temp. 
Store at -20°C
solubility 
DMSO:98.0(Max Conc. mg/mL);274.95(Max Conc. mM)
Ethanol:3.0(Max Conc. mg/mL);8.42(Max Conc. mM)
form 
Solid
color 
Light yellow to yellow
More
Less

None Usage And Synthesis

Uses

BI-1347 is an orally active, selective and potent CDK8 inhibitor (IC50=1.1 nM). BI-1347 shows anti-tumoral activity[1][2].

in vivo

BI-1347 (oral gavage; 10 mg/kg; once daily; 30 d) modulates STAT1 S727 phosphorylation and shows anti-tumor activity in vivo[2].
BI-1347 (oral gavage; 10 mg/kg) intermittent schedule and BI-8382 continuous treatment combination treatment increases efficacy compared to each monotherapy in the mammary carcinoma EMT6 model[2].

Animal Model:B16-F10-luc2 syngeneic melanoma model[2]
Dosage:10 mg/kg
Administration:Oral gavage; 10 mg/kg; once daily; 30 d
Result:Reduced phosphorylation of STAT1 S727 for at least 6 h by 60%.
Showed minimal effect on body weight at 10 mg/kg.
Showed lower tumor burden both on day 23 and 29, compared to the control group.

IC 50

CDK8: 1.1 nM (IC50)

References

[1] Harald Engelhardt, et al. New phenylpyrazolylacetamide compounds and derivatives as cdk8/cdk19 inhibitors.
[2] Hofmann MH, et al. Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance. Mol Cancer Ther. 2020 Apr;19(4):1018-1030. DOI:10.1158/1535-7163.MCT-19-0789

NoneSupplier

Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070
Email
info@chemlin.com.cn
BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com
Sichuan Wei Keqi Biological Technology Co., Ltd.
Tel
028-81700200 18116577057
Email
3003855609@qq.com
Mashilabs (Shanghai) Co.,Ltd.
Tel
19916721580
Email
mafarm@126.com
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266